1. Home
  2. SNBR vs BDTX Comparison

SNBR vs BDTX Comparison

Compare SNBR & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SNBR
  • BDTX
  • Stock Information
  • Founded
  • SNBR 1987
  • BDTX 2014
  • Country
  • SNBR United States
  • BDTX United States
  • Employees
  • SNBR N/A
  • BDTX N/A
  • Industry
  • SNBR Home Furnishings
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • SNBR Consumer Discretionary
  • BDTX Health Care
  • Exchange
  • SNBR Nasdaq
  • BDTX Nasdaq
  • Market Cap
  • SNBR N/A
  • BDTX 323.2M
  • IPO Year
  • SNBR 1998
  • BDTX 2020
  • Fundamental
  • Price
  • SNBR $14.46
  • BDTX $3.31
  • Analyst Decision
  • SNBR Hold
  • BDTX Strong Buy
  • Analyst Count
  • SNBR 3
  • BDTX 4
  • Target Price
  • SNBR $14.17
  • BDTX $15.50
  • AVG Volume (30 Days)
  • SNBR 331.0K
  • BDTX 932.5K
  • Earning Date
  • SNBR 10-30-2024
  • BDTX 11-04-2024
  • Dividend Yield
  • SNBR N/A
  • BDTX N/A
  • EPS Growth
  • SNBR N/A
  • BDTX N/A
  • EPS
  • SNBR N/A
  • BDTX N/A
  • Revenue
  • SNBR $1,781,028,000.00
  • BDTX N/A
  • Revenue This Year
  • SNBR N/A
  • BDTX N/A
  • Revenue Next Year
  • SNBR $2.90
  • BDTX N/A
  • P/E Ratio
  • SNBR N/A
  • BDTX N/A
  • Revenue Growth
  • SNBR N/A
  • BDTX N/A
  • 52 Week Low
  • SNBR $8.13
  • BDTX $1.62
  • 52 Week High
  • SNBR $21.96
  • BDTX $7.66
  • Technical
  • Relative Strength Index (RSI)
  • SNBR 42.68
  • BDTX 33.12
  • Support Level
  • SNBR $14.08
  • BDTX $3.13
  • Resistance Level
  • SNBR $17.08
  • BDTX $3.42
  • Average True Range (ATR)
  • SNBR 1.09
  • BDTX 0.24
  • MACD
  • SNBR -0.29
  • BDTX 0.02
  • Stochastic Oscillator
  • SNBR 14.73
  • BDTX 20.93

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a precision oncology medicine company. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

Share on Social Networks: